Impact of Ketone Metabolites on Inflammasome Deactivation in Gout

酮代谢物对痛风炎症小体失活的影响

基本信息

  • 批准号:
    9216426
  • 负责人:
  • 金额:
    $ 36.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-01 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY: Gout is a debilitating inflammatory disease caused by urate crystal mediated activation of the NLRP3 inflammasome. Aging and metabolic syndrome induced by high-fat diets are major risk factors for Gout. The activation of Nalp3/NLRP3 (for NOD, LRR and pyrin domain containing) by urate crystals induces recruitment and autocatalytic processing of cysteine protease caspase-1 in a large cytosolic protein complex called `inflammasome'. The activation of caspase-1, is required for the cleavage of stored pro-forms of IL-1β and IL-18 proteins into bioactive secreted cytokines. The assembly of inflammasomes requires interaction of pyrin domain (PYD) of ASC (for apoptosis-associated speck like protein containing carboxy terminal CARD) with PYD of Nlrp3 forming a functional inflammasome complex through CARD-CARD (caspase activation recruitment domain ) interaction of ASC with procaspase-1 zymogen. Therefore, the endogenous pathways and metabolites that deactivate the inflammasome have high clinical impact. This proposal is based on our recent findings that ketone metabolite β-hydroxybutyrate (BHB) blocks the NLRP3 inflammasome to regulate the innate immune response. The ketone bodies, BHB and acetoacetate (AcAc) are alternate metabolic fuels that support mammalian survival during periods of starvation by serving as a source of ATP in TCA cycle when glucose reserves are low. Based on our original findings and strong scientific premise1, the central hypothesis of this project is that ketogenic substrate switch underlies the regulatory myeloid responses that dampen metabolic inflammation via inflammasome deactivation. The corollary is that elevating BHB may serve as a treatment for Gout. Using both dietary and transgenic approaches that regulate ketone body metabolism, this proposal will test the mechanism of how BHB controls the inflammasome activation in macrophages and neutrophils. The long-term goal of this project is to develop ketone metabolites as therapeutics against Gout.
项目总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VISHWA DEEP DIXIT其他文献

VISHWA DEEP DIXIT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VISHWA DEEP DIXIT', 18)}}的其他基金

Caloric restriction-driven immunometabolic checkpoints of inflammation
热量限制驱动的炎症免疫代谢检查点
  • 批准号:
    10457565
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
耶鲁小鼠-TMC 对免疫细胞衰老引起的炎症的研究
  • 批准号:
    10675111
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Caloric restriction-driven immunometabolic checkpoints of inflammation
热量限制驱动的炎症免疫代谢检查点
  • 批准号:
    10656332
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Immunometabolic regulation of bone inflammaging
骨炎症的免疫代谢调节
  • 批准号:
    10430514
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Immunometabolic regulation of bone inflammaging
骨炎症的免疫代谢调节
  • 批准号:
    10641819
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
耶鲁小鼠-TMC 对免疫细胞衰老引起的炎症的研究
  • 批准号:
    10553032
  • 财政年份:
    2022
  • 资助金额:
    $ 36.85万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10331167
  • 财政年份:
    2020
  • 资助金额:
    $ 36.85万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10396668
  • 财政年份:
    2020
  • 资助金额:
    $ 36.85万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10667392
  • 财政年份:
    2020
  • 资助金额:
    $ 36.85万
  • 项目类别:
Impact of dysbiosis on the development of age-related inflammation
生态失调对年龄相关炎症发展的影响
  • 批准号:
    10259710
  • 财政年份:
    2020
  • 资助金额:
    $ 36.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了